Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Novel Biomarkers in Patients With Shortness of Breath Attending an Emergency Department

NCT01227317 is registered in ClinicalTrials.gov with ThermoFisher Scientific Brahms Biomarkers France as lead sponsor.

NCT NCT01227317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01227317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Novel Biomarkers in Patients With Shortness of Breath Attending an Emergency Department
Lead sponsor
ThermoFisher Scientific Brahms Biomarkers France
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
September 30, 2011
Enrollment
444 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, ae copd, capd, pulmonary embolism, severe dyspnea